FdaApplication
ANDA 211925
Identifiers
- fda_app_no: ANDA211925
Properties
| Property | Value |
|---|---|
| applicant_name | MICRO LABS LTD |
| application_type | ANDA |
| approval_date | 2022-02-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE | AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE | EQ 12.5MG BASE;5MG | TABLET;ORAL |
| CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE | AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE | EQ 25MG BASE;10MG | TABLET;ORAL |
2 products